- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:46 | Chronic Overmedication: The Polypharmacy Waste and Safety Problem | ||
| 14:46 | In the Absence of Objective Measures for ALS, Caregivers are the Only Witnesses. We Shouldn't Have To Be. | ||
| 14:46 | Valuing Early-Stage Life Sciences Companies: The Why, the How, and the Impact | ||
| 01:46 | Verily & Samsung Team Up to Bring Smartwatch Data into Clinical Trials | ||
| Mo | Eight Sleep Raises $50M to Build Predictive AI for Sleep | ||
| Mo | Alfasigma Pays $300M for Rights to GSK Rare Liver Disease Drug On Track for FDA Decision | ||
| Mo | HIPAA Was Built for an Analog Era, Healthcare AI Has Outgrown It | ||
| Mo | Dialysis Isn't Optional. Transportation Can't Be Either | ||
| Mo | Eyes on the Future: How Retinal Imaging Is Reframing Preventive Medicine | ||
| Mo | Modernizing Care: From Automated Workflows to Smarter Medication Management [Video] | ||
| Mo | It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration? | ||
| Mo | Why This Rural Health System Is Scaling AI for Point-of-Care Decision Making | ||
| So | Roche, Zealand Pharma Obesity Drug Meets Clinical Trial's Weight Loss Goals, But Can It Compete? | ||
| So | Virtual-First Care Shouldn't Spark an "A-Ha" Moment Anymore | ||
| So | For Anthropic, Pragmatism Is the More Trustworthy Position | ||
| So | The Moment is Now: Preventive Cardiac Care is in Sight | ||
| Fr | Why Quantum Health Acquired Virtual Care Company CirrusMD | ||
| Fr | Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma | ||
| Fr | Privacy Expectations in Consumer AI Tools: How Patient Use of ChatGPT Health and Claude Differs From HIPAA-Regulated Care | ||
| Fr | The Healthcare Industry Requires a New Kind of Leader | ||
| Fr | Future of Health Tech: From Structured Data to Scalable AI [Video] | ||
| Fr | Lilly Employer Connect Adds Flexibility for Employers But Isn't Revolutionary, Expert Says | ||
| Do | AI Startups Are Tying Fees to Completed Tasks. Will Hospitals Buy In? | ||
| Do | Startup Atavistik Adds $40M for Clinical Trial in Rare Bleeding Disorder With No Approved Therapies | ||
| Do | How to Build Effective Referral Networks and Improve Patient Navigation [Video] |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.